scanX
Indoco Remedies
add_icon

Indoco Remedies

219.49
+2.80
(1.29%)
Market Cap
2,026.00 Cr
PE Ratio
645.74
Volume
1,20,448.00
Day High - Low
224.78 - 217.05
52W High-Low
332.20 - 162.19
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
2,026.00 Cr
EPS
-10.70
PE Ratio
645.74
PB Ratio
2.16
Book Value
101.76
EBITDA
86.48
Dividend Yield
0.09 %
Industry
Healthcare
Sector
Pharmaceuticals
Return on Equity
-7.65
Debt to Equity
0.78
Analyst Rating and Forecast
- By Refinitiv from4 analysts
HOLD
Analysts have suggested that investors can hold this stock
Buy
Buy0.0 %
0.0 %
Hold
Hold+75.00 %
+75.00 %
Sell
Sell+25.00 %
+25.00 %
Forecast For
Actual

Company News

View All News
Caret
positive
Indoco Remedies Eyes Europe Oral Solid Launch by Q45 days ago
Indoco Remedies targets oral solid drug launches in Europe by Q4, plans INR 260 crore debt repayment over 17-18 months, and aims to keep FY'27 maintenance capex below INR 40-50 crore.
neutral
Indoco Remedies Q4FY26 Earnings Call Recording Available5 days ago
Indoco Remedies Limited has made the audio recording of its earnings conference call for the quarter ended June 30, 2026, available on its website. The call was held on July 28, 2026.
neutral
Indoco Remedies re-appoints Aditi Panandikar as MD5 days ago
Indoco Remedies Board approves re-appointment of Ms. Aditi Panandikar as Managing Director for five years starting Feb 15, 2027, subject to shareholder approval.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Sun Pharmaceutical
1,990.50
#1 4,77,587.60
39.39
#1 61,673.90
12.69
#1 11,565
26.53
66.37
Divis Laboratories
8,056.00
2,13,861.50
83.29
11,067.00
13.95
2,568
65.50
82.30
Torrent Pharmaceuticals
5,122.80
1,94,854.80
90.03
13,886.20
20.34
2,138
3.28
64.10
Cipla
1,473.20
1,19,011.80
35.46
29,044.60
2.24
3,870
-39.18
61.43
Zydus Life Science
1,126.80
1,13,382.40
21.93
27,657.90
17.64
5,026
7.82
53.10
Lupin
2,415.00
1,10,421.70
#1 20.61
29,038.90
#1 26.75
5,356
87.72
49.50
Mankind Pharma
2,469.60
1,01,993.50
49.34
14,636.40
14.85
1,938
29.13
44.89
Laurus Labs
1,816.20
98,048.80
90.00
6,867.80
22.01
890
#1 123.93
81.68
Dr Reddys Laboratories
1,148.10
95,828.40
30.09
35,058.60
3.90
4,158
-69.10
28.48
Aurobindo Pharma
1,580.20
90,921.20
26.19
33,384.70
3.21
3,376
1.99
57.35

Automatic Screeners on ScanX

Community
Resistance 1 Breached
Growth Rate
Revenue Growth
7.34 %
Net Income Growth
40.42 %
Cash Flow Change
-39.42 %
ROE
-187.53 %
ROCE
-104.41 %
EBITDA Margin (Avg.)
-23.29 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
213
237
249
250
248
287
284
264
267
324
334
297
382
374
349
401
396
405
412
429
417
478
461
462
425
432
404
386
433
473
435
460
566
Expenses
206
224
238
224
230
260
255
239
227
268
272
250
300
300
285
329
337
345
337
363
365
410
405
401
384
392
399
391
422
442
420
426
427
EBITDA
7
13
11
26
18
27
30
25
40
56
62
47
82
74
65
72
60
60
74
66
52
68
56
61
42
40
6
-5
10
30
15
34
139
Operating Profit %
3 %
5 %
4 %
9 %
7 %
9 %
10 %
9 %
15 %
17 %
18 %
15 %
21 %
19 %
18 %
18 %
15 %
15 %
18 %
15 %
12 %
13 %
12 %
9 %
10 %
9 %
1 %
-2 %
2 %
6 %
3 %
7 %
9 %
Depreciation
17
18
18
20
17
18
18
18
19
19
17
19
22
20
19
18
20
16
17
18
20
21
24
26
28
29
29
29
30
32
32
33
35
Interest
7
5
4
5
6
5
7
8
6
6
6
5
4
3
4
3
4
5
7
9
8
8
10
12
14
18
16
18
26
25
26
46
28
Profit Before Tax
-12
-10
4
9
-0
10
11
8
24
37
38
34
61
65
51
60
48
67
38
39
34
46
23
33
7
-5
-31
-46
-37
-14
-31
-25
78
Tax
0
-3
-1
-2
-2
2
2
2
7
11
12
9
22
23
18
19
10
18
10
13
10
11
7
11
5
5
-3
-4
-0
-4
-2
-1
12
Net Profit
-12
-7
5
12
2
8
9
5
17
26
25
25
40
42
33
41
39
50
28
26
24
35
16
22
2
-10
-28
-41
-36
-9
-30
-24
65
EPS in ₹
-1.32
-0.81
0.57
1.25
0.20
0.85
0.99
0.58
1.85
2.78
2.75
2.71
4.30
4.52
3.58
4.39
4.19
5.40
3.05
2.80
2.62
3.82
1.69
2.39
0.20
-1.09
-3.08
-4.48
-3.94
-1.00
-3.20
-2.57
7.09
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
846
941
1,197
1,236
1,258
1,272
1,315
1,486
1,658
2,145
2,430
2,593
Fixed Assets
340
374
440
489
468
590
570
555
678
954
997
1,262
Current Assets
385
465
572
537
538
563
623
774
814
955
1,001
1,193
Capital Work in Progress
63
55
91
136
185
51
68
122
114
125
321
28
Investments
0
16
0
0
0
0
0
0
3
9
2
405
Other Assets
443
496
666
612
605
631
677
809
864
1,057
1,111
0
Total Equity & Liabilities
846
941
1,197
1,236
1,258
1,272
1,315
1,486
1,658
2,145
2,430
2,593
Current Liabilities
262
303
390
416
446
459
407
425
425
612
808
1,053
Non Current Liabilities
65
61
155
146
152
133
139
157
205
422
604
609
Total Equity
519
577
651
675
661
680
769
905
1,028
1,111
1,018
939
Reserve & Surplus
500
558
633
657
642
661
751
886
1,010
1,092
1,004
921
Share Capital
18
18
18
18
18
18
18
18
18
18
18
19
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
1
-0
50
-52
12
3
-14
8
-7
4
-3
Investing Activities
-88
-111
-171
-135
-104
-56
-67
-121
-208
-433
-339
Operating Activities
109
112
89
123
132
123
82
174
179
157
95
Financing Activities
-20
-2
132
-39
-16
-64
-30
-44
23
280
241
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
58.69 %
58.69 %
58.69 %
58.69 %
58.69 %
58.69 %
58.69 %
58.69 %
58.69 %
58.74 %
58.74 %
58.72 %
58.75 %
58.75 %
58.80 %
58.90 %
58.90 %
58.90 %
58.90 %
58.86 %
58.86 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.12 %
0.12 %
1.59 %
1.69 %
1.91 %
1.47 %
1.70 %
1.25 %
1.24 %
1.22 %
1.25 %
1.10 %
0.94 %
1.27 %
DIIs
18.88 %
18.80 %
17.22 %
17.23 %
17.64 %
17.52 %
17.33 %
18.07 %
17.29 %
17.78 %
19.56 %
19.41 %
18.67 %
18.24 %
18.90 %
18.75 %
18.96 %
18.16 %
18.15 %
18.15 %
17.68 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
15.92 %
15.92 %
17.32 %
17.87 %
17.87 %
17.23 %
16.85 %
16.74 %
16.48 %
16.84 %
15.24 %
15.33 %
16.29 %
16.30 %
16.07 %
15.99 %
15.79 %
16.40 %
16.48 %
16.56 %
16.68 %
Others
6.52 %
6.59 %
6.78 %
6.21 %
5.80 %
6.57 %
7.13 %
6.39 %
7.42 %
5.04 %
4.77 %
4.62 %
4.81 %
5.01 %
4.99 %
5.12 %
5.14 %
5.29 %
5.38 %
5.48 %
5.50 %
No of Share Holders
21,508
24,518
34,746
37,279
37,863
38,498
38,072
35,713
34,731
36,588
32,600
33,201
34,511
34,416
34,676
34,497
33,129
33,319
32,659
32,276
32,457

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 1.6 1 0.3 0.3 1.5 2.25 2.25 1.5 0.2 0.00
Dividend Yield (%) 0.75 0.49 0.14 0.1 0.4 0.69 0.68 0.64 0.12 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
21 Sept 2021 DIVIDEND Dividend
₹ 1.50 /share
 17 Sept 2021 358.65 473.05
15 Sept 2022 DIVIDEND Dividend
₹ 1.50 /share
 14 Sept 2022 331.60 365.20
16 Sept 2022 DIVIDEND Dividend
₹ 0.75 /share
 14 Sept 2022 331.60 359.35
19 Sept 2023 DIVIDEND Dividend
₹ 2.25 /share
 18 Sept 2023 347.80 356.80
19 Sept 2024 DIVIDEND Dividend
₹ 1.50 /share
 19 Sept 2024 327.55 369.65
26 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 26 Sept 2024 365.50 365.50
24 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 24 Oct 2024 336.65 319.95
21 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 21 Jan 2025 326.65 335.15
22 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 22 May 2025 251.12 261.58
24 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 24 Jul 2025 325.90 310.05
04 Sept 2025 DIVIDEND Dividend
₹ 0.20 /share
 04 Sept 2025 261.58 282.60
11 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 11 Sept 2025 293.70 276.85
06 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 06 Nov 2025 296.85 273.20
03 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 03 Feb 2026 210.96 211.94
07 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 07 May 2026 206.34 227.95
28 Jul 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 28 Jul 2026 248.53 247.75

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication4 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome5 days ago
Announcement under Regulation 30 (LODR)-Change in Management5 days ago
Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June 2026 Along With Limited Review Report5 days ago
Board Meeting Outcome for Outcome Of Board Meeting Held On 28Th July 20265 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 17, 2026
Board Meeting Intimation for Unaudited Results For The Quarter Ended 30-06-2026Jul 15, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2026
Closure of Trading WindowJun 29, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 26, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 11, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 28, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 22, 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsMay 18, 2026
Announcement under Regulation 30 (LODR)-DemiseMay 15, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 14, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 11, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 08, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 07, 2026
Audited Standalone And Consolidated Financial Results For The Quater And Year Ended 31St March 2026May 07, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 07Th May 2026May 07, 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsApr 30, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 30, 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsApr 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 27, 2026
Board Meeting Intimation for Board Meeting Intimation For Audited Results & DividendApr 27, 2026
Update On The Companys Testing Facility At Chhatrapati Sambaji Nagar - AurangabadApr 13, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2026
Announcement Under Regulation 30 Of SEBI LODR-- Intimation Of Re-Appointment Of Cost Auditor And Internal Auditor Of The CompanyMar 31, 2026
Closure of Trading WindowMar 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 13, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 24, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 09, 2026
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Feb 09, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 04, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 03, 2026
Financial Results For The Quarter And Nine Months Ended 31St December 2025Feb 03, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 03/02/2026Feb 03, 2026
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Feb 03, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 03, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 20, 2026
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 16, 2026
Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011Jan 13, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011Dec 31, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 31, 2025
Closure of Trading WindowDec 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 29, 2025
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011Dec 19, 2025

Technical Indicators

RSI(14)
Neutral
39.05
ATR(14)
Less Volatile
12.23
STOCH(9,6)
Neutral
20.55
STOCH RSI(14)
Oversold
3.14
MACD(12,26)
Bearish
-4.21
ADX(14)
Weak Trend
23.50
UO(9)
Bullish
28.55
ROC(12)
Downtrend And Accelerating
-12.05
WillR(14)
Oversold
-93.34
Bearish
3
Neutral
4
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Technical Screeners
Intraday Screeners
Price & Volume Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

© 2025 - 2026 Raise Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357 Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104